Prometheus Laboratories asks Federal Circuit to revive Lotronex patent

04-06-2015

Prometheus Laboratories asks Federal Circuit to revive Lotronex patent

www.BillionPhotos.com / Shutterstock.com

California-based pharmaceutical company Prometheus Laboratories has asked the US Court of Appeals for the Federal Circuit to reinstate a patent covering its irritable bowel syndrome drug Lotronex (alosetron).


Prometheus Laboratories, Roxane, Boehringer Ingelheim, ANDA

LSIPR